Page 110 - MBCA_FULL REPORT_FINAL_FOR_WEB

86. Bennett, B., et al., Fatigue and psychological distress--exploring the relationship in women treated for
breast cancer. Eur J Cancer, 2004. 40(11): p. 1689-95.
87. Stone, P., The measurement, causes and effective management of cancer-related fatigue. Int J Palliat Nurs,
2002. 8(3): p. 120-8.
88. Palesh, O.G., et al., A longitudinal study of depression, pain, and stress as predictors of sleep disturbance
among women with metastatic breast cancer. Biol Psychol, 2007. 75(1): p. 37-44.
89. Carroll, J.K., et al., Pharmacologic treatment of cancer-related fatigue. Oncologist, 2007. 12 Suppl 1: p. 43-
51.
90. Fiorentino, L. and S. Ancoli-Israel, Insomnia and its treatment in women with breast cancer. Sleep Med Rev,
2006. 10(6): p. 419-29.
91. Jagsi, R., et al., Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors
identified through population-based registries. J Clin Oncol, 2014. 32(12): p. 1269-76.
92. Neugut, A.I., et al., Association between prescription co-payment amount and compliance with adjuvant
hormonal therapy in women with early stage breast cancer. J Clin Oncol, 2011. 29(18): p. 2534-42.
93. Zafar, S.Y., et al., The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses
and the insured cancer patient’s experience. Oncologist, 2013. 18(4): p. 381-90.
94. Ramsey, S., et al., Washington State cancer patients found to be at greater risk for bankruptcy than people
without a cancer diagnosis. Health Aff (Millwood), 2013. 32(6): p. 1143-52.
95. Buzaglo, J., et al., Work-related impact of metastatic breast cancer: Results from the Cancer Experience
Registry., in 7th Biennial Cancer Survivorship Research Conference. 2014: Atlanta, GA.
96. Yang, H.C., et al., Surviving recurrence: psychological and quality-of-life recovery. Cancer, 2008. 112(5): p.
1178-87.
97. English, R.A., Y. Lebovitz, and R.B. Giffin, Transforming Clinical Trials in the United States: Challenges and
Opportunities. A workshop summary. 2010.
98. Duggan, M., Pew Research Internet Project, Cell Phone Activities 2013: Additional Demographics, in Pew
Research Internet Project. 2013: Pew Research.
99. DeSantis, C.E., et al., Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin, 2014. 64(4): p.
252-71.
100. Clements, M.S., et al., Estimating prevalence of distant metastatic breast cancer: a means of filling a data
gap. Cancer Causes Control, 2012. 23(10): p. 1625-34.
101. Fiteni, F., et al., Long-term survival of patients with HER2 metastatic breast cancer treated by targeted
therapies. , in Thirty-Fifth Annual CTRC-AACR San Antonio Breast Cancer Symposium. 2012, Cancer Research:
San Antonio, TX.

102. Dawood, S., et al., Survival differences among women with de novo stage IV and relapsed breast cancer.
Ann Oncol, 2010. 21(11): p. 2169-74.
103. Dawood, S., et al., Trends in survival over the past two decades among white and black patients with newly
diagnosed stage IV breast cancer. J Clin Oncol, 2008. 26(30): p. 4891-8.

104. Chia, S.K., et al., The impact of new chemotherapeutic and hormone agents on survival in a population-
based cohort of women with metastatic breast cancer. Cancer, 2007. 110(5): p. 973-9.
105. Giordano, S.H., et al., Is breast cancer survival improving? Cancer, 2004. 100(1): p. 44-52.
106. Ruiterkamp, J., et al., Improved survival of patients with primary distant metastatic breast cancer in the
period of 1995-2008. A nationwide population-based study in the Netherlands. Breast Cancer Res Treat, 2011.
128(2): p. 495-503.
110